Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 7 studies | 34% ± 11% | |
| ciliated cell | 7 studies | 28% ± 8% | |
| retina horizontal cell | 5 studies | 25% ± 9% | |
| type II pneumocyte | 5 studies | 29% ± 20% | |
| basal cell | 4 studies | 27% ± 9% | |
| hepatocyte | 4 studies | 40% ± 28% | |
| endothelial cell | 3 studies | 24% ± 3% | |
| goblet cell | 3 studies | 22% ± 5% | |
| transit amplifying cell | 3 studies | 23% ± 3% | |
| oligodendrocyte | 3 studies | 23% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 4378.07 | 258 / 258 | 100% | 34.83 | 230 / 230 |
| kidney | 100% | 2204.01 | 89 / 89 | 100% | 16.78 | 901 / 901 |
| liver | 100% | 4452.21 | 226 / 226 | 100% | 30.24 | 406 / 406 |
| ovary | 100% | 1912.99 | 180 / 180 | 100% | 10.89 | 430 / 430 |
| pancreas | 100% | 1147.66 | 328 / 328 | 100% | 11.46 | 178 / 178 |
| thymus | 100% | 2156.60 | 653 / 653 | 100% | 20.03 | 605 / 605 |
| brain | 100% | 1496.21 | 2641 / 2642 | 100% | 18.29 | 705 / 705 |
| intestine | 100% | 1333.82 | 966 / 966 | 100% | 17.41 | 526 / 527 |
| prostate | 100% | 2390.93 | 245 / 245 | 100% | 31.40 | 501 / 502 |
| stomach | 100% | 1274.24 | 359 / 359 | 100% | 13.11 | 285 / 286 |
| skin | 100% | 1500.72 | 1809 / 1809 | 100% | 12.71 | 470 / 472 |
| uterus | 100% | 1452.04 | 170 / 170 | 100% | 17.60 | 457 / 459 |
| breast | 100% | 1637.80 | 459 / 459 | 99% | 14.52 | 1112 / 1118 |
| esophagus | 100% | 1572.37 | 1445 / 1445 | 99% | 9.40 | 182 / 183 |
| bladder | 100% | 1395.57 | 21 / 21 | 99% | 16.90 | 501 / 504 |
| lung | 100% | 1548.95 | 576 / 578 | 100% | 14.50 | 1152 / 1155 |
| adipose | 100% | 1390.28 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 15.92 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 18.06 | 29 / 29 |
| spleen | 100% | 1095.93 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 19.03 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 15.91 | 1 / 1 |
| blood vessel | 100% | 1161.10 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1253.42 | 800 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 1403.99 | 852 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 44% | 578.02 | 406 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0009235 | Biological process | cobalamin metabolic process |
| GO_0005759 | Cellular component | mitochondrial matrix |
| GO_0016765 | Molecular function | transferase activity, transferring alkyl or aryl (other than methyl) groups |
| GO_0031419 | Molecular function | cobalamin binding |
| GO_0008817 | Molecular function | corrinoid adenosyltransferase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | MMAB |
| Protein name | Metabolism of cobalamin associated B Corrinoid adenosyltransferase MMAB (EC 2.5.1.-) (ATP:co(I)rrinoid adenosyltransferase MMAB) (Methylmalonic aciduria type B protein) |
| Synonyms | |
| Description | FUNCTION: Converts cob(I)alamin to adenosylcobalamin (adenosylcob(III)alamin), a coenzyme for methylmalonyl-CoA mutase, therefore participates in the final step of the vitamin B12 conversion . Generates adenosylcobalamin (AdoCbl) and directly delivers the cofactor to MUT in a transfer that is stimulated by ATP-binding to MMAB and gated by MMAA (Probable). . |
| Accessions | ENST00000540016.5 Q96EY8 ENST00000537496.5 S4R3P5 ENST00000545712.7 S4R3Z1 ENST00000541763.6 F5H4Z7 ENST00000420167.6 F5H0C1 F5H079 ENST00000544051.5 ENST00000503497.7 ENST00000537236.2 A0A087X114 |
